Managed Account Advisors’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Managed Account Advisors’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$11K	Sell	275 -99,496	-100%	-$3.57M	﹤0.01%	2875
2015 Q1	$3.52M	Sell	99,771 -7,448	-7%	-$252K	﹤0.01%	1589
2014 Q4	$3.44M	Sell	107,219 -8,641	-7%	-$250K	﹤0.01%	1568
2014 Q3	$3.25M	Sell	115,860 -7,049	-6%	-$215K	﹤0.01%	1582
2014 Q2	$3.71M	Sell	122,909 -80,197	-39%	-$2.21M	﹤0.01%	1520
2014 Q1	$5.62M	Sell	203,106 -13,513	-6%	-$354K	0.01%	1260
2013 Q4	$5.53M	Sell	216,619 -2,011	-0.9%	-$62K	0.01%	1250
2013 Q3	$6.53M	Sell	218,630 -58,766	-21%	-$1.63M	0.01%	1129
2013 Q2	$7.97M	Buy	+277,396	New	+$7.64M	0.01%	976

Other funds holding BRLI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Managed Account Advisors's BRLI Position: Q2 2015 in Review

Managed Account Advisors reduced its BIO-REFERENCE LABS INC-NEW- (BRLI) stake by 100% in Q2 2015, selling an estimated $3.57M and leaving 275 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #2875.

Managed Account Advisors first reported a position in BRLI in Q2 2013 and has held it in 9 quarters since. The position peaked at $7.97M in Q2 2013. 183 funds tracked by Wall St. Rank hold BRLI as of Q2 2015.

Managed Account Advisors held 275 shares of BIO-REFERENCE LABS INC-NEW- worth $11K as of Q2 2015.
Managed Account Advisors sold 99,496 BIO-REFERENCE LABS INC-NEW- shares in Q2 2015, an estimated $3.57M.
BIO-REFERENCE LABS INC-NEW- made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #2875 holding.
Managed Account Advisors first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and has held it in 9 quarters since.
Managed Account Advisors's BIO-REFERENCE LABS INC-NEW- position peaked at $7.97M in Q2 2013.
183 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.